Lung cancer risk prediction: A tool for early detection

被引:78
作者
Cassidy, Adrian
Duffy, Stephen W.
Myles, Jonathan P.
Liloglou, Triantafillos
Field, John K.
机构
[1] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Program, Liverpool L3 9TA, Merseyside, England
[2] Canc Res UK, Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London, England
基金
英国医学研究理事会;
关键词
lung neoplasm; risk prediction; high-risk; early detection; biomarker;
D O I
10.1002/ijc.22331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although 45% of men and 39% of women will be diagnosed with cancer in their lifetime, it is difficult to predict which individuals will be affected. For some cancers, substantial progress in individual risk estimation has already been made. However, relatively few models have been developed to predict lung cancer risk beyond effects of age and smoking. This paper reviews published models for lung cancer risk prediction, discusses their potential contribution to clinical and research settings and suggests improvements to the risk modeling strategy for lung cancer. The sensitivity and specificity of existing cancer risk models is less than optimal. Improvement in individual risk prediction is important for selection of individuals for prevention or early detection interventions. In addition to smoking, factors related to occupational exposure, personal medical history and family history of cancer can add to the predictive power. A good risk prediction model is one that can identify a small fraction of the population in which a large proportion of the disease cases will occur. In the future, genetic and other biological markers are likely to be useful, although they will require rigorous evaluation. Validation is essential to establish the predictive effect and for ongoing monitoring of the model's continued relevance. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 78 条
[1]   Epidemiology of lung cancer: Looking to the future [J].
Alberg, AJ ;
Brock, MV ;
Samet, JM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) :3175-3185
[2]  
Amos CI, 1999, RECENT RESULTS CANC, V151, P3
[3]  
[Anonymous], CANC PRINCIPLES PRAC
[4]  
[Anonymous], NAT INV CANC RES PLA
[5]   Variations in lung cancer risk among smokers [J].
Bach, PB ;
Kattan, MW ;
Thornquist, MD ;
Kris, MG ;
Tate, RC ;
Barnett, MJ ;
Hsieh, LJ ;
Begg, CB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) :470-478
[6]   A major lung cancer susceptibility locus maps to chromosome 6q23-25 [J].
Bailey-Wilson, JE ;
Amos, CI ;
Pinney, SM ;
Petersen, GM ;
de Andrade, M ;
Wiest, JS ;
Fain, P ;
Schwartz, AG ;
You, M ;
Franklin, W ;
Klein, C ;
Gazdar, A ;
Rothschild, H ;
Mandal, D ;
Coons, T ;
Slusser, J ;
Lee, J ;
Gaba, C ;
Kupert, E ;
Perez, A ;
Zhou, X ;
Zeng, D ;
Liu, Q ;
Zhang, Q ;
Seminara, D ;
Minna, J ;
Anderson, MW .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (03) :460-474
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   Gene-promoter hypermethylation as a biomarker in lung cancer [J].
Belinsky, SA .
NATURE REVIEWS CANCER, 2004, 4 (09) :707-717
[9]  
Cassidy A, 2006, INT J ONCOL, V28, P1295
[10]   Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present [J].
Chanin, TD ;
Merrick, DT ;
Franklin, WA ;
Hirsch, FR .
CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (04) :242-247